Intracellular Antiviral Activity of Low-Dose Ritonavir in Boosted Protease Inhibitor Regimens

Protease inhibitors are largely used for the treatment of HIV infection in combination with other antiretroviral drugs. Their improved pharmacokinetic profiles can be achieved through the concomitant administration of low doses of ritonavir (RTV), a protease inhibitor currently used as a booster, in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: De Nicolò, Amedeo, Simiele, Marco, Calcagno, Andrea, Mohamed Abdi, Adnan, Bonora, Stefano, Di Perri, Giovanni, D'Avolio, Antonio
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2014
Schlagworte:
Antiviral Agents
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068548/
https://ncbi.nlm.nih.gov/pubmed/24798279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00104-14
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge